VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GPATGP-Act III Acquisition Corp.
$10.88$391M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksGPATQuarterly Financials

GP-Act III Acquisition Corp. (GPAT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

GP-Act III Acquisition Corp. (GPAT) quarterly income statement — complete revenue, gross profit & net income history

GPAT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q1'23Q1'21
Sales/Revenue------------
Revenue Growth %------------
Cost of Goods Sold------------
COGS % of Revenue------------
Gross Profit000000000000
Gross Margin %------------
Gross Profit Growth %------------
Operating Expenses565.28K84.2K126.33K141.33K200.05K184.36K143.46K177.41K59.74K12.11K70035
OpEx % of Revenue------------
Selling, General & Admin565.28K84.2K126.33K141.33K200.05K184.36K143.46K177.41K59.74K12.11K70035
SG&A % of Revenue------------
Research & Development------------
R&D % of Revenue------------
Other Operating Expenses------------
Operating Income-565.28K-84.26K-126.33K-141.33K-200K-184K-143K-177K-59.74K-12.11K-700-35
Operating Margin %------------
Operating Income Growth %-182.64%54.21%11.66%20.15%-234.8%-1419.66%---8434%---
EBITDA-565.28K-84.26K-126.33K-141.33K-200K-184K-143K-177K-59.74K-12.11K-700-30
EBITDA Margin %------------
EBITDA Growth %-182.64%54.21%11.66%20.15%-234.8%-1419.66%---8434%---
D&A (Non-Cash Add-back)000000000000
EBIT-565.28K-84.26K-126.33K-141.33K-200K-184K-143K-177K-59.74K-12.11K-700-35
Net Interest Income2.72M-9.47M3.23M3.13M3.11M3.49M3.8M1.95M0000
Interest Income2.72M-9.47M3.23M3.13M3.11M3.49M3.8M1.95M0000
Interest Expense000000000000
Other Income/Expense------------
Pretax Income2.15M2.89M3.11M2.98M2.91M3.3M3.66M1.77M-59.74K-12.11K-700-35
Pretax Margin %------------
Income Tax000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%
Net Income2.15M2.89M3.11M2.98M2.91M3.3M3.66M1.77M-59.74K-12.11K-700-35
Net Margin %------------
Net Income Growth %-25.92%-12.41%-15.05%68.53%4966.25%27387.74%---8434%---
Net Income (Continuing)2.15M2.89M3.11M2.98M2.91M3.3M3.66M1.77M-59.74K-12.11K-700-35
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)0.060.080.090.080.080.090.100.08-0.00--0.000.00
EPS Growth %-25.83%-12.5%-10%3.88%--------
EPS (Basic)0.060.080.090.080.080.090.100.05-0.00-0.00-0.000.00
Diluted Shares Outstanding28.75M28.75M28.75M35.94M35.94M35.94M35.94M21.91M31.25M31.25M31.25M31.25M
Basic Shares Outstanding28.75M28.75M28.75M35.94M35.94M35.94M35.94M35.94M31.25M18.77M31.25M31.25M
Dividend Payout Ratio------------